NASHVILLE, Tenn. / Aug 12, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present at the following healthcare conferences:
September 5, 2024 at 8:00am ET at the 2024 Wells Fargo Healthcare Conference at the Encore Boston Arbor in Everett, MA.
September 5, 2024 at 3:20pm ET at Morgan Stanley’s 22nd Annual Global Healthcare Conference at the Marriott Marquis in New York, NY.
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.
Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 188 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom.
All references to “Company” and “HCA” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.
| Last Trade: | US$311.25 |
| Daily Change: | 3.04 0.99 |
| Daily Volume: | 1,840,548 |
| Market Cap: | US$78.840B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
